The Economics of Obesity

In this episode, Dr. Matthew Weiner and Zoe Schroeder dive into the latest developments in weight loss medications, the economics of obesity, and practical tips for those who have undergone or are considering bariatric surgery.
Welcome to Episode 5 of the Pound of Cure Weight Loss Podcast. In this episode, Dr. Matthew Weiner and Zoe Schroeder dive into the latest developments in weight loss medications, the economics of obesity, and practical tips for those who have undergone or are considering bariatric surgery. From discussing the newly FDA-approved GLP-1 medications for weight loss to addressing common issues like acid reflux after VSG, this episode is packed with actionable insights and patient-focused advice. Whether you’re exploring self-pay options for weight loss drugs or simply want to learn more about optimizing your diet post-surgery, this episode has something for you.
Let’s break down the key topics covered in this informative episode.
The Power of GLP-1 Medications for Weight Loss
One of the most exciting recent developments in weight loss treatment is the introduction of GLP-1 medications for weight loss. These medications, such as Zepbound (Tirzepatide) and Wegovy (Semaglutide), have been shown to produce significant weight loss results. In fact, Zepbound has now been approved by the FDA specifically for weight loss, and Dr. Weiner describes it as one of the most effective tools available today.
Why Are GLP-1 Medications Effective for Weight Loss?
GLP-1 medications mimic a hormone in your body called Glucagon-like Peptide-1 (GLP-1), which plays a crucial role in regulating blood sugar levels and appetite. These medications help patients feel fuller longer, reduce food noise, and ultimately consume fewer calories without feeling deprived. They essentially reset your metabolic thermostat, helping you lose weight without the constant battle against hunger.
During the podcast, Dr. Weiner shares remarkable data showing that patients on Zepbound experience weight loss levels similar to those seen in bariatric surgery. For example, diabetics have lost an average of 21% of their body weight on Zepbound, while non-diabetics also see up to 26% total weight loss—compared to lower rates with Ozempic and Wegovy.
Who Benefits Most from GLP-1 Medications?
GLP-1 medications are particularly effective for people who:
- Struggle with obesity and have found it difficult to lose weight through diet and exercise alone.
- Have diabetes or pre-diabetes, as these medications help manage both blood sugar and weight loss.
- Post-op bariatric surgery patients looking for additional weight loss or to maintain the results of surgery.
The effectiveness of GLP-1 medications for weight loss cannot be understated, and Dr. Weiner believes these drugs will dominate the weight loss market for the next several years.
Exploring Self-Pay Options for Weight Loss Drugs
For many patients, the biggest hurdle when it comes to accessing GLP-1 medications like Zepbound is cost. Insurance coverage for weight loss medications can be inconsistent, making it difficult for some people to afford these life-changing drugs. That’s where self-pay options for weight loss drugs come into play.
Why Are Weight Loss Drugs So Expensive?
One of the recurring themes in this episode is the high cost of weight loss medications, specifically GLP-1 agonists. Dr. Weiner explains that although the production costs for these drugs are relatively low (about $20-$30), pharmaceutical companies set prices much higher—Zepbound costs around $550 per month, even with a coupon.
The issue is further complicated by supply chain challenges. These supply shortages drive prices up and make it harder for patients to get consistent access to their medications.
How to Manage the Costs: Self-Pay Options for Weight Loss Drugs
For patients who need these medications but struggle to afford them, Dr. Weiner suggests several self-pay options for weight loss drugs:
- Coupon Programs: Many pharmaceutical companies offer coupon programs that can significantly reduce the cost of medications. Zepbound, for example, has a coupon that can bring the cost down to $550 per month.
- Stretching Medications: Dr. Weiner mentions that patients can sometimes stretch their medication to last longer than the prescribed month. For example, with careful guidance, some patients use smaller doses or inject every 10-14 days, which can make the medication last longer.
- Canadian Pharmacies: In some cases, medications like Mounjaro (Tirzepatide) are available in Canada at much lower prices. Purchasing vials from Canadian pharmacies can offer a more affordable option for some patients, though it’s crucial to consult with your healthcare provider before doing so.
While these self-pay options can make GLP-1 medications more affordable, Dr. Weiner reminds listeners that stretching medication doses or sourcing them from other countries should only be done with professional guidance to ensure patient safety.
Another self-pay option is our Pound of Cure Platinum program where we use creative dosing strategies to bring the cost down to often less than what you would pay for compounded medications.
Dealing with Acid Reflux After VSG
A significant portion of the episode is dedicated to a common issue faced by many bariatric patients—acid reflux after VSG (Vertical Sleeve Gastrectomy). While VSG is an effective weight loss surgery, many patients experience gastroesophageal reflux disease (GERD) as a side effect.
What Causes Acid Reflux After VSG?
Dr. Weiner explains that acid reflux after VSG occurs for several reasons. The vertical sleeve gastrectomy involves removing about 80% of the stomach, which reduces its capacity but also changes the anatomy of the stomach and esophagus. This alteration can increase pressure on the esophagus and decrease the effectiveness of the lower esophageal sphincter (the valve that keeps stomach acid from flowing upward).
In some patients, the VSG surgery can also cause a narrowing or kinking of the stomach, increasing pressure and contributing to acid reflux. For others, pre-existing GERD can worsen after VSG surgery.
Managing Acid Reflux After VSG: Non-Surgical and Surgical Options
Managing acid reflux after VSG is essential to maintaining a high quality of life post-surgery. Dr. Weiner highlights several strategies that patients can use to alleviate their symptoms:
- Medication: Many patients find relief by using proton pump inhibitors (PPIs) like Prilosec or Prevacid, which reduce stomach acid production.
- Dietary Adjustments: Patients should avoid foods that trigger reflux, such as acidic foods (citrus, tomatoes), spicy foods, and fatty meals. Foods that relax the stomach like some tea’s and mint can also worsen acid reflux. Eating smaller, more frequent meals and avoiding large portions can also help minimize reflux symptoms.
- Weight Loss: While surgery helps with significant weight loss, maintaining that loss can reduce pressure on the esophagus and alleviate GERD symptoms.
- Revision Surgery: In severe cases, patients may need to revise their sleeve to a Roux-en-Y gastric bypass (RYGB), which can effectively reduce or eliminate acid reflux. Dr. Weiner shares that about 5% of VSG patients will require this revision surgery due to persistent GERD.
Dr. Weiner stresses the importance of addressing reflux symptoms early on. Left untreated, acid reflux can lead to more serious complications like Barrett’s esophagus, a condition where the lining of the esophagus changes due to repeated exposure to stomach acid, increasing the risk of esophageal cancer.
The Role of GLP-1 Medications in Post-Surgery Weight Maintenance
Another valuable discussion in this episode centers on the synergy between bariatric surgery and GLP-1 medications for weight loss. Many bariatric patients struggle with weight regain after surgery or need additional help to achieve their target weight. GLP-1 medications, like Zepbound, have proven to be an effective option for post-op patients.
How GLP-1 Medications Help Post-Op Patients
Dr. Weiner explains that GLP-1 medications can help quiet the food noise, regulate appetite and prevent the gradual weight regain that sometimes occurs after bariatric surgery. These medications work by suppressing hunger and slowing digestion, which mirrors some of the effects of surgery itself.
One common misconception is that patients who have undergone weight loss surgery won’t benefit from medications like Zepbound. However, Dr. Weiner explains that surgery and medications work on the same hormonal pathways and can be highly complementary. In fact, some of his patients have seen weight loss results similar to those of first-time surgery patients when combining the two treatments.
Conclusion: Combining Tools for Success
Episode 5 of the Pound of Cure Weight Loss Podcast is an insightful conversation that covers crucial aspects of weight loss treatment, from the latest GLP-1 medications to acid reflux after VSG. Dr. Weiner and Zoe provide a well-rounded perspective, emphasizing that the combination of tools—whether it’s surgery, medication, or dietary changes—offers the best chance for long-term success.
If you’re looking for more information on self-pay options for weight loss drugs or need guidance on managing post-surgery complications, this episode provides invaluable advice. Remember, each journey is unique, and the goal is to find the right combination of treatments that work for your body and lifestyle.